Fanconi Anemia

Disease Overview

Fanconi Anemia (FA) is a rare, inherited genetic disorder characterized by bone marrow failure, congenital physical abnormalities, and a significantly increased risk of developing cancer. It is a complex genetic condition that affects multiple body systems and can have varying degrees of severity among affected individuals.

Disease Category

Rare Genetic Disorder
Inherited Bone Marrow Failure Syndrome
Chromosomal Instability Syndrome

Synonyms

FA
Fanconi Pancytopenia
Fanconi Anemia Syndrome

Signs & Symptoms

Physical manifestations include: - Congenital abnormalities - Short stature - Skeletal malformations - Kidney anomalies - Skin pigmentation changes - Cardiac defects - Reproductive system abnormalities

Hematological symptoms: - Bone marrow failure - Anemia - Thrombocytopenia - Leukopenia - Increased risk of blood cancers

Additional complications: - Higher susceptibility to solid tumors - Developmental delays - Endocrine disorders

Causes

Genetic Factors: - Mutations in DNA repair genes (at least 22 identified genes) - Primary genes include FANCA, FANCC, FANCG - Autosomal recessive inheritance pattern - Requires mutation in both parental gene copies

Affected Populations

Worldwide distribution
Prevalence: Approximately 1 in 160,000 live births
Equal gender distribution
Higher incidence in:
- Ashkenazi Jewish populations
- Afrikaners in South Africa

Disorders with Similar Symptoms

Dyskeratosis Congenita
Shwachman-Diamond Syndrome
Diamond-Blackfan Anemia
Seckel Syndrome
Bloom Syndrome

Diagnosis

Diagnostic Methods: - Comprehensive clinical evaluation - Detailed family history - Chromosome breakage tests - Genetic mutation analysis - Bone marrow biopsy - Molecular genetic testing - Prenatal genetic screening

Standard Therapies

Treatment Approaches: - Blood transfusions - Androgen therapy - Hematopoietic stem cell transplantation - Cancer screening and management - Surgical interventions for congenital abnormalities - Genetic counseling - Supportive care

Clinical Trials and Studies

Current Research Focus: - Gene therapy - Advanced stem cell treatments - Cancer prevention strategies - Long-term outcome studies - Molecular mechanism investigations

References

National Institutes of Health
Fanconi Anemia Research Fund publications
Genetic and Rare Diseases Information Center
International scientific journals

Programs & Resources

Fanconi Anemia Research Fund (FARF)
National Organization for Rare Disorders (NORD)
NIH Rare Diseases Clinical Research Network
Genetic Support Foundation

Complete Report

Fanconi Anemia is a complex genetic disorder requiring comprehensive, multidisciplinary management. Early diagnosis, ongoing monitoring, and advanced therapeutic approaches are crucial for improving patient outcomes and quality of life.

Farconi Anemia